The Metals Company
The Metals Company Announces Second Quarter 2025 Corporate Update Conference Call for Thursday, August 14, 2025
The Metals Company Announces Second Quarter 2025 Corporate Update Conference Call for Thursday, August 14, 2025
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world’s largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Thursday, August 14, 2025, to provide an update on second quarter 2025 financial results and recent corporate developments.
Second Quarter 2025 Conference Call Details
Date: | Thursday, August 14, 2025 |
Time: | 4:30 p.m. ET |
Audio-only Dial-in: | Register Here |
Virtual webcast with slides: | Register Here |
The virtual webcast will be available for replay in the ‘Investors’ tab of the Company’s website under ‘Investors’ > ‘Media’ > ‘Events and Presentations’, approximately two hours after the event.
The Metals Company is a developer of lower-impact critical metals from seafloor polymetallic nodules, on a dual mission: (1) supply metals for energy, defense, manufacturing and infrastructure with net positive impacts compared to conventional production routes and (2) trace, recover and recycle the metals we supply to help create a metal commons that can be used in perpetuity. The Company has conducted more than a decade of research into the environmental and social impacts of offshore nodule collection and onshore processing. More information is available at www.metals.co.
Contacts
Media | media@metals.co
Investors | investors@metals.co
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Boehringer Ingelheim Limited8.8.2025 21:25:53 CEST | Press release
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
European Investment Bank8.8.2025 18:07:24 CEST | Press release
EIB submits SEC Form 18-K/A Amendment No. 4 - Unaudited Condensed Semi-Annual Financial Statements as at and for the six-month period ended June 30, 2025
European Investment Bank8.8.2025 18:04:10 CEST | Press release
EIB submits Form 18-K/A Amendment No.3 - December 2024 EIB Group Risk Management Disclosure Report
SBM Offshore Amsterdam B.V.8.8.2025 18:01:27 CEST | Press release
FPSO ONE GUYANA producing and on hire
Vaisala Group8.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 8.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom